LOUISVILLE, Ky., Feb. 6, 2025 /PRNewswire/ -- Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the ...

Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...

Evercore ISI analyst Chirag Ved maintained a Buy rating on Confluent (CFLT – Research Report) on February 7 and set a price target of $32.00.

Scotiabank analyst Nick Altmann maintained a Hold rating on Confluent (CFLT – Research Report) today and set a price target of $27.00. The company’s shares closed yesterday at $29.17.

This is a breaking news story. Details will be added soon. Please refresh the page for latest version.

after a "very nice bath" at the confluence of the Ganga, Yamuna and (mythical) Saraswati rivers in Prayagraj. "... it was not a very big incident. I don't know how big it was (but) it is being ...

At this time, I'd like to welcome everyone to The Coca-Cola Company's fourth-quarter and full-year 2024 earnings results ...